Published Research Confirms Safety Of Biocell Collagen II Study confirms oral safety findings published in the scientific journal, Food And Chemical Toxicology.
For Immediate Release NEWPORT BEACH, Calif./EWORLDWIRE/March 21, 2007 --- A study published in February's issue of Food and Chemical Toxicology has confirmed the safety of BioCell Collagen II(R), a dietary ingredient that supports connective tissue health in joints and skin. The research was comprised of two oral toxicity studies involving acute and subchronic tests. Test subjects exhibited no toxicity, even at 33 times the recommended dose, as observed by a review of a variety of biomarkers and histopathological examinations. The publication - which only publishes high-quality research to assist in health and safety decisions - disclosed that the wide variety of toxicity studies performed on the ingredient affirmed BioCell Collagen II to be safe for use as an oral health food supplement. BioCell Technology Vice President Suhail Ishaq said, "The affirmation on the safety of BioCell Collagen II reflects a significant advance in today's health food industry. BioCell Collagen II is the only dietary ingredient of its kind to undergo the rigors of toxicity testing. Consumers can be confident about the safety BioCell Collagen II, and it opens the door to new product development in the functional foods market. With this toxicity study behind us, along with other studies that we have commissioned, our next goal is to achieve GRAS certification." A patented, dietary ingredient, BioCell Collagen II is composed of a minimum 60 percent Hydrolyzed Collagen Type II, 20 percent Chondroitin Sulfate, and 10 percent Hyaluronic Acid (HA). As a particularly rich source of bioavailable HA, it works to promote joint and skin health. BioCell Collagen II can be found in dozens of dietary supplements made by leading multinational companies. For more information on this innovative dietary ingredient, visit http://www.biocelltechnology.com. Study reference: Schauss, A.G., Merkel, D.J., Glaza, S.M., Sorensonet, S.R., et al. (2007). Acute and subchronic oral toxicity studies in rats of a hydrolyzed chicken sternal cartilage preparation. Food and Chemical Toxicology, 45 (2), 315-321. About BioCell Technology Founded in 1997, BioCell Technology, LLC pioneered the applications of Sternum Collagen Type II, the highest concentrated natural source available of type II collagen. It is the exclusive supplier of BioCell Collagen II(R). BioCell Technology, LLC owns the exclusive rights to market BioCell Collagen II(R) under the United States Patents #6,025,327, 6,323,319, 6,780,841. BioCell Collagen II is a branded registered logo that is available for display on its clients' labels to market under their own brand name or formulas. For more information on BioCell Collagen II, contact Toni Dizon at BioCell Technology, LLC at (714) 632-1231, or visit http://www.biocelltechnology.com. HTML: http://www.eworldwire.com/pressreleases/16673 PDF: http://www.eworldwire.com/pdf/16673.pdf ONLINE NEWSROOM: http://www.eworldwire.com/newsroom/311008.htm NEWSROOM RSS FEED: http://newsroom.eworldwire.com/xml/newsrooms/311008.xml LOGO: http://www.eworldwire.com/newsroom/311008.htm CONTACT: Toni Dizon BioCell Technology, LLC 4695 MacArthur Court 11th Floor Newport Beach, CA 92660 PHONE. 7146321231 EMAIL: [EMAIL PROTECTED]
